Alpha 2.0
Login Register
» Articles » PMID: 37901150

A Case of Perioral Dermatitis Successfully Treated with Abrocitinib

Overview
Journal Clin Cosmet Investig Dermatol
Publisher Dove Medical Press
Specialty Dermatology
Date 2023 Oct 30
PMID 37901150
Authors
Yan Teng
Mingyang Ren
Yang Ding
Xianhong Yang
Yibin Fan
Xiaohua Tao
Affiliations
Soon will be listed here.
Abstract

Perioral dermatitis (POD) is a chronic inflammatory skin disease that primarily affects females between the ages of 16 and 45. Conventional therapies face the challenge of limited efficacy and a high recurrence rate. In this report, we present the case of a 26-year-old male patient with POD who was successfully treated using the Janus kinase (JAK) inhibitor, abrocitinib. This treatment exhibited both good efficacy and safety. Abrocitinib, as a JAK inhibitor, holds promise as a potential therapy for cases of POD that might be resistant to conventional therapies.

Citing Articles

Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology.

Dogra S, Shah S, Gupta M, Sharma A, Chhabra S Indian Dermatol Online J. 2024; 15(6):930-941.

PMID: 39640454 PMC: 11616915. DOI: 10.4103/idoj.idoj_449_24.

Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis.

Mitroi G, Mitroi G, Ica O, Anghelina F, Ciolofan M, Mitroi M Life (Basel). 2024; 14(9).

PMID: 39337910 PMC: 11432974. DOI: 10.3390/life14091127.

A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib.

Wu H, Ji Q, Xu Y, Zhu J Clin Cosmet Investig Dermatol. 2024; 17:843-846.

PMID: 38628635 PMC: 11020286. DOI: 10.2147/CCID.S455060.

References
1.
Bao C, Xu Q, Xiao Z, Wang H, Luo R, Cheng B . Abrocitinib as a novel treatment for lichen sclerosus. Br J Dermatol. 2023; 189(1):136-138. DOI: 10.1093/bjd/ljad129. View
2.
Bai J, Su W, Fang H, Qiao J . Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases. Int J Dermatol. 2023; 62(9):e480-e483. DOI: 10.1111/ijd.16698. View
3.
Bennett M, Moussa A, Sinclair R . Successful treatment of chronic severe alopecia areata with abrocitinib. Australas J Dermatol. 2022; 63(2):274-276. DOI: 10.1111/ajd.13836. View
4.
Noguera-Morel L, Gerlero P, Torrelo A, Hernandez-Martin A . Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases. J Am Acad Dermatol. 2017; 76(3):567-570. DOI: 10.1016/j.jaad.2016.10.034. View
5.
Does A, Yosipovitch G . Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib. Dermatitis. 2023; 34(6):567. DOI: 10.1089/derm.2022.0065. View